Form 4: Bioventus Inc. Director Susan M. Stalnecker Reports Stock Transaction
SEC Form 4 Filing
Director Susan M. Stalnecker reports the vesting and subsequent disposal of 30,400 Class A Common Stock restricted stock units on June 7, 2024.
Summary
- On June 7, 2024, Susan M. Stalnecker, a director of Bioventus Inc. [BVS], had 30,400 restricted stock units (RSUs) vest.
- Each RSU represents a contingent right to receive one share of Class A common stock.
- Following the transaction, Stalnecker directly owns 79,464 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: This is a routine disclosure of insider transactions, neither particularly positive nor negative.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, such as directors and officers, ensuring fair market practices.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 06/07/2024 | Date of transaction: vesting of restricted stock units and disposal of shares. |
| 06/11/2024 | Date of report signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.